Synthesis and biophysical studies on 35-Deoxy amphotericin b methyl ester

Chemistry - A European Journal

Volumn 15, Issue 29, 2009, Pages 7117-7128

  Szpilman, Alex M ^a   Cereghetti, Damiano M ^a   Manthorpe, Jeffrey M ^a   Wurtz, Nicholas R ^a   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Amphotericin b; Antifungal agents; Natural products; Structure activity relationship; Total synthesis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENTS; NATURAL PRODUCTS; STRUCTURE-ACTIVITY RELATIONSHIP; TOTAL SYNTHESIS;

ESTERIFICATION; ESTERS; MINING;

FUNGICIDES;

AMPHOTERICIN B; AMPHOTERICIN B METHYL ESTER; DRUG DERIVATIVE; GLYCOSIDE; HEXOSAMINE; MYCOSAMINE;

ARTICLE; BIOPHYSICS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

AMPHOTERICIN B; BIOPHYSICAL PHENOMENA; GLYCOSIDES; HEXOSAMINES; MOLECULAR STRUCTURE;

EID: 67650665790     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200900231     Document Type: Article

References (124)

1. a) Macrolide Antibiotics, Chemistry, Biology and Practice (Ed.: S. Omura), Academic Press, New York, 1984;
2. b) for a recent review see: D. M. Cereghetti, E. M. Carreira, Synthesis 2006, 914-942.
3. T. H. Sternberg, E. T. Wright, M. Oura, Antibiot. Annu. 1956, 566573.
4. a) H. A. Gallis, R. H. Drew, W. W. Pickard, Rev. Infect. Dis. 1990, 12, 308-329;
5. b) I, M, Hann, H, G. Prentice, Int. J. Antimicrob. Agents 2001, 17, 161-169.
6. A. Lemke, A. F. Kiderlen, O. Kayser, Appl Microbiol. Biotechnol. 2005, 68, 151-162.
7. P. Ganis, G. Avitabile, W. Mechlin, C. P. Schaffner, J. Am. Chem. Soc. 1971, 93, 4560-4564.
8. Selected synthetic approaches towards amphotericin B: a) S. Hanessian, S. P. Sahoo, M. Botta, Tetrahedron Lett. 1987, 28, 1143-1146;
9. b)T. Berkenbusch, R. Brueckner, Chem. Eur. J. 2004, 10, 1545-1557;
10. c) C. Bonini, L. Chiummiento, A. Martuscelli, L. Viggiani, Tetrahedron Lett. 2004, 45, 2177-2179;
11. d) K. Karisalmi, K. Rissanen, A. M. P. Koskinen, Org. Biomoi Chem. 2003, 1, 3193-3196;
12. e) K. Karisalmi, A. M, P. Koskinen, M. Nissinen, K. Rissanen, Tetrahedron 2003, 59,1421-1427;
13. f) G. Solladié, N. Wilb, C. Bauder, Eur. J. Org. Chem. 1999, 3021-3026;
14. g) G. Solladie, X Hutt, Tetrahedron Lett. 1987, 28, 797-800;
15. h)G.J. McGarvey, J.M. Williams, R.N. Hiner, Y. Matsubara, T. Oh, J. Am. Chem. Soc. 1986, 108, 4943-4952;
16. i) J.M, Williams, G.J. McGarvey, Tetrahedron Lett. 1985, 26, 4891-4894.
17. See: a) K. C. Nicolaou, T. K. Chakraborty, Y. Ogawa, R. A, Daines, N. S. Simpkins, G. T. Fürst, J. Am. Chem. Soc. 1988, 110, 4660-4672;
18. b) K. C. Nicolaou, R. A. Daines, J. Uenishi, W. S. Li, D. P. Papahatjis, T. K. Chakraborty, J. Am. Chem. Soc. 1988, 110, 4672-4685;
19. c) K. C. Nicolaou, R. A. Daines, T. K. Chakraborty, Y. Ogawa, J. Am. Chem. Soc. 1988, 110, 4685-4696;
20. d) K, C. Nicolaou, R. A. Daines, Y. Ogawa, T. K. Chakraborty, J. Am. Chem. Soc. 1988, 110, 4696-4705;
21. e) for another seminal, contribution see the synthesis of the aglycone: R. M. Kennedy, A. Abiko, T. Takemasa, H. Okumoto, S. Masamune, Tetrahedron Lett.1988, 29, 451-454.
22. For the synthesis of the candidin aglycon, see: I. Kadota, Y. Hu, G. K. Packard, S. D. Rychnovsky, Proc. Natl. Acad. Sci USA 2004, 101, 11992-11995;
23. for the synthesis of the rimocidin aglycon, see: G. K. Packard, Y. Hu, A, Vescovi, S. D. Rychnovsky, Angew. Chem. 2004, 116, 2882-2886;
24. Angew. Chem. Int. Ed. 2004, 43, 2822-2826.
25. For a leading review, see: S. C. Hartsel, C. Hatch, W Ayenew, J. Liposome Res. 1993, 3, 377-408.
26. a) A. Finkelstein, R. HoIz in Membranes (Ed.: G. Eisenman), Marcel Dekker, New York, 1973, pp. 377-408;
27. b) A. Marty, A. Finkelstein, J. Gen. Physiol. 1975, 65, 515-526;
28. c) R. W. Holz, Ann. N. Y. Acad, Sci 1974, 235, 469-479.
29. a) B. De Kruijff, W. J. Gerritsen, A. Oerlemans, R. A. Demel, L. L. M. Van Deenen, Biochim. Biophys. Acta Biomembr. 1974, 339, 30-43;
30. b) B. De Kruijff, W. J. Gerritsen, A. Oerlemans, P. W. M. Van Dijck, R. A. Demel, L. L. M. Van Deenen, Biochim. Biophys. Acta Biomembr. 1974, 339, 44-56;
31. c) B. De Kruijff, R. A. Demel, Biochim. Biophys. Acta Biomembr. 1974, 339, 57-70;
32. d) A. W. Norman, Biochim. Biophys. Acta Biomembr. 1972, 290, 1-14
33. a) J. Brajtburg, S. Elberg, D. R. Schwartz, A. Vertut-Croquin, D. Schlessinger, G. S. Kobayashi, G. Medoff, Antimicrob. Agents Chemother. 1985, 27, 172-176;
34. b)M. L. Sokol-Anderson, J. Brajtburg, G. Medoff, J. Infect. Dis. 1986, 154, 76-83.
35. M, Baginski, H, Resat, J. A. Mccammon, Mol. Pharmacol. 1997, 52, 560-570.
36. a) For the preparation of an analogue of amphotericin B lacking the carboxylic acid group, see: M. Carmody, B. Murphy, B. Byrne, P. Power, D. Rai, B. Rawlings, P. Caffrey, J. Biol. Chem. 2005, 280, 34420-34426;
37. b) A semisynthetic approach to this same molecule has also recently been reported: D.S. Palacios, T.M. Anderson, M. D. Burke, J. Am. Chem. Soc. 2007, 129, 13804-13805.
38. a) B. N. Rogers, M. E. Selsted, S.D. Rychnovsky, Bioorg. Med. Chem. 1997, 5, 3177-3182;
39. b) For a fluorinated polyene analogue whose biological profile has not been determined, see: H. Tsuchikawa, N. Matsushita, N. Matsumori, M. Murata, T. Oishi, Tetrahedron Lett. 2006, 47, 6187-6191
40. V. Paquet, E. M, Carreira, Org. Lett. 2006, 8, 1807-1809, and references therein.
41. a) A. Zumbuehl, P. Stano, M. Sohrmann, T. Vigassy, E. Pretsch, M. Peter, P. Walde, D. Jeannerat E. M. Carreira, Angew. Chem. 2004, 116, 5293-5297;
42. Angew. Chem. Int. Ed. 2004, 43, 5181.-5185;
43. b) A. Zumbuehl, P. Stano, M. Sohrmann, M, Peter, P. Walde, E. M, Carreira, Org. Biomol. Chem. 2007, 5, 1339-1342;
44. c)V. Paquet, A. Zumbuehl, E. M. Carreira, Bioconjugate Chem. 2006, 17, 1460-1463;
45. d) A. Zumbuehl, P Stano, D. Heer, P. Walde, E. M. Carreira, Org. Lett. 2004, 6, 3683-3686.
46. For a preliminary report, see: a) A. M. Szpilman, D. M, Cereghetti, N. R. Wurtz, J. M, Manthorpe, E. M. Carreira, Angew. Chem. 2008, 120, 4407-4410;
47. Angew. Chem. Int. Ed. 2008, 47, 4335-4338;
48. b) A. M. Szpilman, J. M. Manthorpe, E. M. Carreira, Angew. Chem. 2008, 120, 4411-4414;
49. Angew. Chem. Int. Ed. 2008, 47, 4339-4341.
50. We have previously disclosed full accounts of our gram scale syntheses of the C33-C38 fragment: J. Tholander, E. M, Carreira, HeIv. Chim. Acta 2001, 84, 613-622;
51. and the mycosamine subunit; J. M. Manthorpe, A. M, Szpilman, E. M. Carreira, Synthesis 2005, 3380-3388.
52. Professor Danishefsky suggested that diverted total synthesis could be used as way to perform "molecular editing" of undesired or unnecessary structural features of natural, products: R. M. Wilson, S. J. Danishefsky, J. Org. Chem. 2006, 71, 8329-8351
53. a) R. A, Singer, E. M, Carreira, J. Am. Chem. Soc. 1995, 117, 12360-12361;
54. b) E. M. Carreira, R. A. Singer, Drug Discovery Today 1996, 1, 145-150;
55. c) J. Krüger, E. M. Carreira, J. Am. Chem. Soc. 1998, 120, 837-838;
56. d) J. Krüger, E. M. Carreira, Tetrahedron Lett. 1998, 39, 7013-7016;
57. e) Y. Kim, R. A. Singer, E. M. Carreira, Angew. Chem. 1998, 110, 1261-1263;
58. f) B. L. Pagenkopf, J. Krüger, A. Stojanovic, E. M. Carreira, Angew. Chem. 1998, 110, 3312-3314;
59. Angew. Chem. Int. Ed. 1998, 37, 3124-3126;
60. g) R. Singer, J. Brock, E. M. Carreira, Helv. Chim. Acta 2003, 86,1040-1044.
61. K.-M. Chen, G. E. Hardtmann, K. Prasad, O. Repic, M. J. Shapiro, Tetrahedron Lett. 1987, 28,155-158.
62. D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277-7287.
63. P. L. Anelli, C. Biffi, F. Montanari, S. Quici, J. Org. Chem. 1987, 52, 2559-2562.
64. S. Ohira, Synth. Commun. 1989, 19, 561 -564.
65. a) S. Saito, T. Hasegawa, M. Inaba, R. Nishida, T. Fujii, S. Nomizu, T. Moriwake, Chem. Lett. 1984, 1389-1392;
66. b) S. Saito, T. Ishikawa, A. Kuroda, K. Koga, T. Moriwake, Tetrahedron 1992, 48, 4067-4086.
67. a) G. Wess, K, Kesseler, E. Baader, W. Bartmann, G. Beck, A. Bergmann, H, Jendralla, K. Bock, G. Holzstein, H. Kleine, M, Schnierer, Tetrahedron Lett. 1990, 31, 2545-2548;
68. b) J. L. Hubbs, C. H. Heathcock, J. Am. Chem. Soc. 2003, 125,12836-12843.
69. a) J. A. Dale, H. S. Mosher, J. Am. Chem. Soc, 1973, 95, 512-519;
70. b) G. R. Sullivan, J. A. Dale, H. S. Mosher, J. Org. Chem. 1973, 38, 2143-2147;
71. c) I, Ohtani, T. Kusumi, Y. Kashman, H. Kakisawa, J. Am. Chem. Soc. 1991, 113, 4092-4096.
72. See the Supporting Information
73. a) D. E. Frantz, R. Fässler, E. M. Carreira, J. Am Chem. Soc.2000, 122,1806-1807;
74. b) N. K. Anand, E. M. Carreira, J. Am. Chem. Soc. 2001, 123, 9687-9688;
75. c)D. Boyall, F. Lopez, H. Sasaki, D. Frantz, E. M, Carreira, Org. Lett. 2000, 2, 4233-4236;
76. d) H, Sasaki, D. Boyall, E. M, Carreira, HeIv. Chim. Acta 2001, 84, 964-971;
77. e) R. Sans-Diez, B. Adger, E. M, Carreira, Tetrahedron 2002, 58, 8341 -8344;
78. f) For an application in total, synthesis, see: A. Fettes, E. M. Carreira, Angew. Chem. 2002, 114, 4272-4275;
79. Angew. Chem. Int. Ed. 2002, 41, 4098-4101;
80. g) S. Reber, T. F. Knoepfel, E. M. Carreira, Tetrahedron 2003, 59, 6813-6817;
81. h) F. Kleinbeck, E. M. Carreira, Angew. Chem. 2009, 121, 586-589;
82. Angew. Chem. Int. Ed. 2009, 48, 578-581.
83. D. A, Evans, E. B. Sjogren, J. Bartroli, R. L. Dow, Tetrahedron Lett. 1986, 27, 4957-4960.
84. a) B. O. Lindgren, T. Nilsson, Acta Chem. Scand. 1973, 27, 888-890;
85. b) B. S. Bal, W. E. Childers, H. W. Pinnick, Tetrahedron 1981, 37, 2091-2096.
86. D. A. Evans, T. C. Britton, J. A. Ellman, Tetrahedron Lett. 1987, 28, 6141-6144.
87. a) J. W. Bode, N. Frafel, D. Muri, E. M. Carreira, Angew. Chem. 2001, 113, 2128-2131;
88. Angew. Chem. Int. Ed. 2001, 40, 2082-2085;
89. b)L. Fader, E. M. Carreira, Org. Lett. 2004, 6, 2485-2488;
90. c) N. Lohse-Fraefel, E. M, Carreira, Org. Lett. 2005, 7, 2011-2014;
91. d) N. Becker, E. M. Carreira, Org. Lett. 2007, 9, 3857-3860; For applications in total, synthesis, see:
92. e) D. Muri, N. Lohse, E. M, Carreira, Angew. Chem. 2005, 117, 4104-4106;
93. Angew. Chem, Int. Ed. 2005, 44, 4036-4038.
94. F. Kleinbeck, E. M. Carreira, Angew. Chem. 2008, 120, 596-598;
95. Angew. Chem. Int. Ed. 2008, 47, 586-589.
96. This method was reported by the McGarvey group in their synthetic studies towards amphotericin B (1) using a different homoallylic acohol. See: a) G. J. McGarvey, J.A. Mathys, K.J. Wilson, J. Org. Chem. 1996, 61, 5704-5705;
97. b)G. J. McGarvey, J.A. Mathys, K.J. Wilson, Tetrahedron Lett. 2000, 41, 6011-6015;
98. NMR analysis of hemiketal 32 and 33 indicated that the expected anti product was formed.
99. P. G. Baraldi, A. Barco, S. Benneti, S. Manfredini, D. Simoni, Synthesis 1987, 276-278.
100. A. Guarna, A. Guidi, A. Goti, A. Brandi, F. De Sarlo, Synthesis 1989,175-178.
101. a) G. Fráter, Helv. Chim. Acta 1979, 62, 2825-2828;
102. b) D. Seebach, D. Wasmuth, Helv. Chim. Acta 1980, 63,197-200.
103. A. G. Myers, B. H, Yang, H, Chen, L. McKinstry, D. J. Kopecký, J. L. Gleason, J. Am. Chem. Soc. 1997, 119, 6496-6511
104. J. Inanaga, K. Hirata, H, Saeki, T. Katsuki, M. Yamaguchi, Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993.
105. I. Shiina, R. Ibuka, M. Kubota, Chem. Lett. 2002, 286-287.
106. M, A. Blanchette, W. Choy, J. T. Davis, A. P. Essenfeld, S. Masamune, W. Roush, T. Sakai, Tetrahedron Lett. 1984, 25, 2183-2186.
107. I. Paterson, K.-S. Yeung, J. B. Smaill, Synlett 1993, 774-776.
108. L. K. Blasdel, A. G. Myers, Org. Lett.2005, 7, 4281-4283.
109. a) A. V. Demchenko, Synlett 2003, 1225-1240;
110. b) E. S. H. El. Ashry, N. Rashed, E. S. I. Ibrahim, Curr. Org. Synth. 2005, 2,175-213.
111. a) R. L. Halcomb, S.J. Danishefsky, J. Am Chem Soc. 1989, 111, 6661-6666;
112. b) D. Kahne, S. Walker, Y. Cheng, D. Van Engen, J.Am. Chem. Soc. 1989, 111, 6881-6882;
113. c) G. K, Packard, S. D. Rychnovsky, Org. Lett. 2001, 5, 3393-3396.
114. a) N. K, Kochetkov, A. Y. Khorlin, A. F. Bochkov, Tetrahedron 1967, 23, 693-707;
115. b) For a recent review, see: F. Kong, Carbohydr. Res. 2007, 342, 345-373.
116. a) A related approach was recently published, see: H. Yu, D. L. Williams H, E. Ensley, Tetrahedron Lett. 2005, 46, 3417-3421; See also:
117. b) G. Desmares, D. Lefebvre, G. Renevret, C. Le Drian, HeIv. Chim. Acta 2001, 84, 880-889.
118. Glycoside tosylates have been reported to be capable of glycosidating simple alcohols: R. Eby, C. Schuerch, Carbohydr. Res. 1974, 34, 79-90.
119. Treating 53 with LiOH led to formation of a complex mixture of products. A complex mixture of byproducts is also formed during azide reduction with basic triethylamine and 1,3-propanedithiol, The base sensitivity of amphotericin B derivatives is highly dependant on structure. Chemical evidence in support of this supposition is the fact that while saponification of amphotericin B methyl, ester (AME) with LiOH proceeds cleanly, hydrolysis of the acetonide protected amphotericin B methyl ester leads to epimerization, presumably at C34.
120. V. Paquet, A. A. Volmer, E. M, Carreira, Chem. Eur. J. 2008, 14, 2465-2481
121. a) P. van Hoogevest, B. de Kruijff, Biochim. Biophys. Acta Biomembr. 1978, 511, 397-407;
122. b) D. S. Orlov, T. Nguyen and R. I. Lehrer, J. Microbiol. Methods 2002, 49, 325-328.
123. The width of the phospholipid bilayer of these LUVs is 37 Â and thus any formation of single barrel ion channels should be precluded. See supporting information for additional measurements.
124. A. M, Szpilman, E. M. Carreira, Org. Lett. 2009, 11, 1305-1307.